ConsumerLab.com uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.

About ConsumerLab.com

Answer:

There is currently only preliminary evidence to support the use of N-acetyl-glucosamine (NAG) in treating inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. For details, see the "NAG" section of the Glucosamine and Chondroitin Supplements Review >>

Join today to unlock all member benefits including full access to all CL Answers and over 1,300 reviews.

Join Now

Join now at www.consumerlab.com/join/

Comments

Be the first to comment

(0/2500)

Join today to unlock all member benefits including full access to CL Answers

Join Now

Join now at www.consumerlab.com/join/